Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Anatomic Variation | 3 | 2019 | 20 | 0.97 | Why? |
| Bicuspid | 1 | 2019 | 9 | 0.79 | Why? |
| Tooth Root | 1 | 2019 | 13 | 0.79 | Why? |
| Maxilla | 1 | 2019 | 70 | 0.74 | Why? |
| Anatomic Landmarks | 1 | 2018 | 44 | 0.73 | Why? |
| Software Validation | 1 | 2017 | 5 | 0.70 | Why? |
| Salivary Gland Diseases | 1 | 2017 | 17 | 0.69 | Why? |
| Mandible | 1 | 2018 | 72 | 0.69 | Why? |
| Abdominal Fat | 1 | 2017 | 43 | 0.68 | Why? |
| Radiography, Thoracic | 6 | 2021 | 5486 | 0.56 | Why? |
| Cone-Beam Computed Tomography | 3 | 2019 | 118 | 0.51 | Why? |
| Splenic Vein | 1 | 2012 | 9 | 0.49 | Why? |
| Renal Veins | 1 | 2012 | 13 | 0.49 | Why? |
| Spinal Fractures | 3 | 2019 | 124 | 0.48 | Why? |
| Esophageal Diseases | 1 | 2012 | 34 | 0.46 | Why? |
| Neovascularization, Pathologic | 1 | 2014 | 305 | 0.42 | Why? |
| Endoscopy | 4 | 2017 | 1564 | 0.42 | Why? |
| Paranasal Sinus Diseases | 1 | 2009 | 39 | 0.39 | Why? |
| Aromatase Inhibitors | 2 | 2019 | 45 | 0.36 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2012 | 669 | 0.33 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.33 | Why? |
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 869 | 0.33 | Why? |
| Liver Neoplasms | 2 | 2019 | 1666 | 0.32 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2012 | 669 | 0.30 | Why? |
| Italy | 12 | 2021 | 38444 | 0.28 | Why? |
| Carcinoma, Hepatocellular | 1 | 2014 | 1222 | 0.27 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.26 | Why? |
| Magnetic Resonance Imaging | 3 | 2017 | 6551 | 0.26 | Why? |
| Mycoses | 1 | 2009 | 589 | 0.25 | Why? |
| Liver Cirrhosis | 1 | 2014 | 1810 | 0.24 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.23 | Why? |
| X-Rays | 2 | 2021 | 492 | 0.23 | Why? |
| Bevacizumab | 2 | 2019 | 149 | 0.22 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.21 | Why? |
| Tomography, X-Ray Computed | 7 | 2019 | 25144 | 0.21 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.20 | Why? |
| Carcinoma, Lobular | 1 | 2019 | 62 | 0.20 | Why? |
| Cranial Fossa, Posterior | 1 | 2018 | 10 | 0.19 | Why? |
| Mandibular Nerve | 1 | 2018 | 7 | 0.18 | Why? |
| Sella Turcica | 1 | 2017 | 9 | 0.18 | Why? |
| Carcinoma, Ductal, Breast | 1 | 2019 | 149 | 0.18 | Why? |
| Sphenoid Sinus | 1 | 2017 | 26 | 0.18 | Why? |
| Ethmoid Sinus | 1 | 2017 | 10 | 0.17 | Why? |
| Lymphoma, B-Cell, Marginal Zone | 1 | 2017 | 44 | 0.17 | Why? |
| Glottis | 1 | 2017 | 48 | 0.17 | Why? |
| Lung Neoplasms | 3 | 2020 | 3228 | 0.17 | Why? |
| Sialadenitis | 1 | 2017 | 31 | 0.17 | Why? |
| Neuroendoscopy | 1 | 2018 | 99 | 0.17 | Why? |
| Oropharyngeal Neoplasms | 1 | 2018 | 138 | 0.16 | Why? |
| Retrospective Studies | 13 | 2021 | 105322 | 0.16 | Why? |
| Subcutaneous Fat | 1 | 2017 | 94 | 0.16 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.15 | Why? |
| Male | 25 | 2021 | 367725 | 0.15 | Why? |
| Thyroxine | 1 | 2018 | 250 | 0.15 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.15 | Why? |
| Osteoporotic Fractures | 1 | 2018 | 175 | 0.15 | Why? |
| Antineoplastic Agents, Immunological | 2 | 2020 | 830 | 0.15 | Why? |
| Laryngectomy | 1 | 2017 | 145 | 0.14 | Why? |
| Dysgeusia | 1 | 2020 | 524 | 0.14 | Why? |
| Aged | 20 | 2020 | 215776 | 0.14 | Why? |
| Laryngeal Neoplasms | 1 | 2017 | 202 | 0.14 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.14 | Why? |
| Arteries | 1 | 2017 | 283 | 0.14 | Why? |
| Radiography, Dual-Energy Scanned Projection | 1 | 2014 | 53 | 0.14 | Why? |
| Pericarditis | 1 | 2020 | 417 | 0.14 | Why? |
| Neuroendocrine Tumors | 1 | 2018 | 241 | 0.14 | Why? |
| Intra-Abdominal Fat | 1 | 2017 | 227 | 0.14 | Why? |
| Salvage Therapy | 1 | 2017 | 417 | 0.14 | Why? |
| Models, Organizational | 1 | 2020 | 908 | 0.14 | Why? |
| Incidental Findings | 1 | 2019 | 487 | 0.14 | Why? |
| Radiographic Image Enhancement | 1 | 2014 | 89 | 0.14 | Why? |
| Adipose Tissue | 1 | 2019 | 612 | 0.13 | Why? |
| Natural Language Processing | 1 | 2018 | 436 | 0.13 | Why? |
| Mouth Mucosa | 1 | 2017 | 323 | 0.13 | Why? |
| Fluorodeoxyglucose F18 | 2 | 2021 | 1153 | 0.13 | Why? |
| Middle Aged | 21 | 2021 | 270681 | 0.13 | Why? |
| Information Storage and Retrieval | 1 | 2018 | 644 | 0.12 | Why? |
| Thyroid Neoplasms | 1 | 2018 | 422 | 0.12 | Why? |
| Imaging, Three-Dimensional | 1 | 2018 | 680 | 0.12 | Why? |
| Radiopharmaceuticals | 1 | 2017 | 763 | 0.12 | Why? |
| Peripheral Nervous System Neoplasms | 1 | 2011 | 4 | 0.12 | Why? |
| Masseter Muscle | 1 | 2011 | 9 | 0.12 | Why? |
| Nasal Cavity | 1 | 2018 | 909 | 0.12 | Why? |
| Humans | 37 | 2021 | 930598 | 0.12 | Why? |
| Sex Characteristics | 1 | 2020 | 1120 | 0.12 | Why? |
| Neurilemmoma | 1 | 2011 | 17 | 0.11 | Why? |
| Data Mining | 1 | 2018 | 767 | 0.11 | Why? |
| Ventricular Dysfunction, Left | 1 | 2020 | 993 | 0.11 | Why? |
| Positron Emission Tomography Computed Tomography | 2 | 2021 | 1458 | 0.11 | Why? |
| Anastomosis, Surgical | 1 | 2012 | 169 | 0.11 | Why? |
| Chemotherapy, Adjuvant | 3 | 2019 | 606 | 0.11 | Why? |
| Female | 22 | 2020 | 380317 | 0.11 | Why? |
| Magnetic Resonance Angiography | 1 | 2012 | 282 | 0.10 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.10 | Why? |
| Breast Neoplasms | 2 | 2019 | 3633 | 0.10 | Why? |
| Computed Tomography Angiography | 1 | 2020 | 2153 | 0.10 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.10 | Why? |
| Papillomavirus Infections | 1 | 2018 | 861 | 0.10 | Why? |
| Lung Diseases, Interstitial | 1 | 2021 | 1476 | 0.10 | Why? |
| Interferon-alpha | 1 | 2018 | 1442 | 0.10 | Why? |
| Nasal Mucosa | 1 | 2017 | 1218 | 0.10 | Why? |
| Adult | 13 | 2020 | 244371 | 0.09 | Why? |
| Aged, 80 and over | 9 | 2020 | 88759 | 0.09 | Why? |
| Reproducibility of Results | 2 | 2017 | 11304 | 0.09 | Why? |
| Respiratory Tract Infections | 1 | 2009 | 6817 | 0.09 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1573 | 0.09 | Why? |
| Neoplasm Staging | 3 | 2020 | 1999 | 0.09 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.08 | Why? |
| Sex Factors | 2 | 2020 | 11014 | 0.08 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.08 | Why? |
| Melanoma | 1 | 2017 | 1229 | 0.07 | Why? |
| Bone Density | 2 | 2019 | 335 | 0.07 | Why? |
| Antineoplastic Agents | 2 | 2018 | 3550 | 0.07 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.07 | Why? |
| Colorectal Neoplasms | 1 | 2019 | 1884 | 0.07 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.07 | Why? |
| Surgical Procedures, Operative | 1 | 2020 | 2662 | 0.07 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.07 | Why? |
| Head and Neck Neoplasms | 1 | 2017 | 1568 | 0.07 | Why? |
| Medical Oncology | 1 | 2020 | 3826 | 0.07 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.07 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| Disease-Free Survival | 2 | 2018 | 1654 | 0.06 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.06 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.06 | Why? |
| Contrast Media | 2 | 2019 | 1011 | 0.05 | Why? |
| Home Care Services, Hospital-Based | 1 | 2020 | 137 | 0.05 | Why? |
| Absorptiometry, Photon | 1 | 2019 | 168 | 0.05 | Why? |
| Erlotinib Hydrochloride | 1 | 2018 | 48 | 0.05 | Why? |
| Interatrial Block | 1 | 2018 | 19 | 0.05 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Ethmoid Bone | 1 | 2017 | 34 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.04 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.04 | Why? |
| Postmenopause | 1 | 2019 | 160 | 0.04 | Why? |
| Chemoradiotherapy | 1 | 2020 | 362 | 0.04 | Why? |
| Osteoporosis, Postmenopausal | 1 | 2018 | 75 | 0.04 | Why? |
| Protein-Tyrosine Kinases | 1 | 2018 | 158 | 0.04 | Why? |
| Prevalence | 4 | 2021 | 25773 | 0.04 | Why? |
| Algorithms | 1 | 2014 | 7346 | 0.04 | Why? |
| Adiposity | 1 | 2019 | 329 | 0.04 | Why? |
| Turbinates | 1 | 2017 | 205 | 0.04 | Why? |
| Decision Trees | 1 | 2018 | 441 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 317 | 0.04 | Why? |
| Thyrotropin | 1 | 2018 | 262 | 0.04 | Why? |
| Tumor Burden | 1 | 2017 | 369 | 0.04 | Why? |
| Thyroidectomy | 1 | 2018 | 207 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Dissection | 1 | 2017 | 164 | 0.04 | Why? |
| Neoplasm Metastasis | 1 | 2018 | 682 | 0.04 | Why? |
| Microsurgery | 1 | 2017 | 166 | 0.04 | Why? |
| Neoplasm Invasiveness | 1 | 2017 | 582 | 0.04 | Why? |
| Laser Therapy | 1 | 2017 | 158 | 0.04 | Why? |
| Troponin T | 1 | 2020 | 771 | 0.03 | Why? |
| Papillomaviridae | 1 | 2018 | 404 | 0.03 | Why? |
| Creatinine | 1 | 2020 | 1443 | 0.03 | Why? |
| Sensitivity and Specificity | 1 | 2014 | 22971 | 0.03 | Why? |
| Cadaver | 1 | 2017 | 626 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Smell | 1 | 2020 | 1851 | 0.03 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.03 | Why? |
| Shock, Septic | 1 | 2020 | 1313 | 0.03 | Why? |
| Radiography | 1 | 2018 | 1576 | 0.02 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.02 | Why? |
| Demography | 1 | 2017 | 1660 | 0.02 | Why? |
| Treatment Outcome | 2 | 2017 | 51732 | 0.02 | Why? |
| Child | 1 | 2019 | 70012 | 0.02 | Why? |
| Peptide Fragments | 1 | 2020 | 2075 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Molecular Targeted Therapy | 1 | 2018 | 1579 | 0.02 | Why? |
| Carcinoma, Squamous Cell | 1 | 2017 | 902 | 0.02 | Why? |
| Adolescent | 1 | 2019 | 86841 | 0.02 | Why? |
| Odds Ratio | 1 | 2019 | 5861 | 0.02 | Why? |
| Pilot Projects | 1 | 2019 | 5182 | 0.02 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2020 | 53120 | 0.02 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Atrial Fibrillation | 1 | 2020 | 2320 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2018 | 2844 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.02 | Why? |
| Liver | 1 | 2017 | 4007 | 0.02 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Heart Failure | 1 | 2020 | 6638 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
Maroldi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(199)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(231)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_